However, TGFβ1 secreted by tumor cells inhibits iCAF formation by antagonizing IL1 signaling activity and prevents myCAF conversion to iCAF by blocking the JAK/STAT pathway [19]. This evidence concerns the gene IL1B and neoplasm.